Interested in #PNH? Join us in Paris for the 2nd Scientific Conference on PNH!

📅 Dates: May 15-16, 2025
📍 Location: Novotel Paris Centre Eiffel Tower.

ipig2025.com/program

🎥 In a fantastic interview from #IPIG2025, Catherine Flynn discusses the characterization of breakthrough hemolysis events in patients with PNH treated with crovalimab or eculizumab on the COMMODORE 1 & 2 trials:

👉 buff.ly/iDKWfRa

#CTSM #RareDisease #Hematology #MedSky #BloodSky

Want to learn about the prevention of thrombosis in patients with PNH?🩸

Make sure to watch our recent interview from #IPIG2025 with @marrow.bsky.social‬ of @petermaccc.bsky.social‬ in which he discusses this:

🎥 buff.ly/i8Ry0Zr

#RareDisease #Hematology #Thrombosis #BloodSky #MedSky

What are the adverse events associated with proximal and terminal complement inhibition in patients with PNH?🩸

Watch our interview from #IPIG2025 with ‪Benjamin Chin-Yee (@bc-y.bsky.social‬) to find out:

👉 buff.ly/DCfWF6o 👈

#RareDisease #PNH #Hematology #BloodSky #HemeSky #MedSky

What’s new in #PNH?🩸

This week's podcast episode highlights key takeaways from #IPIG2025, including challenging clinical scenarios & valuable insights from the COMMODORE trials.

🎧 Click here to listen:
👉 ow.ly/I5a550W5nvb

#Hematology #RareDisease #CTSM #TrialUpdate

At #IPIG2025, we spoke to Pat Garcia-Gonzalez, co-founder & CEO of @themaxfoundation.org‬, to learn about the projects of this important organization.🌍🩸

Find out how the Max Foundation is revolutionizing treatment access & accelerating health equity:

🎥 buff.ly/gm7hrSt

#CMLsm #Leusm

Proud to share that Pascale Burmester spoke on behalf of the PNH Global Alliance at the 2nd IPIG Conference in Paris 🇫🇷 on the role of patient advocates in R&D.
Key takeaway: collaboration leads to better, more impactful outcomes! 💡🌍
#PNH #PatientAdvocacy #IPIG2025

Is it possible to discontinue anticoagulation in patients with PNH?🩸🤔

Dr Richard Kelly commented on this in a recent interview at #IPIG2025, which you can watch by clicking here:

👉 buff.ly/WEm7Ga6 👈

#Hematology #PNH #MedSky #BloodSky #HemeSky

Last week, in a session at #IPIG2025, Jens Panse discussed the complexities of switching patients with PNH from C5 inhibitors to proximal complement inhibitors.

Hear what he had to say:
👉 buff.ly/mwY2TlW 👈

#Hematology #PNH #RareDisease #BloodSky #HemeSky #MedSky